Life Sciences & Pharma Executive Insights Approaching Japan’s Increasingly Challenging and Subjective Drug Pricing Environment November 17, 2020 Companies need to understand Japan’s pricing system and anticipate and plan for potential challenges both in advance of and subsequent to launch.
Life Sciences & Pharma Executive Insights Maximizing Oncology Success Through World-Class Guideline and Compendia Strategies February 18, 2020 National Comprehensive Cancer Network (NCCN) recommendations are considered to be the gold standard for public and private insurers to use in making…
MedTech Presentations The New Future of US Telehealth: Lasting Impacts of COVID-19 April 23, 2020 COVID-19 has necessitated a broad increase in telehealth’s role across mainstream care delivery use cases, driven by social distancing, need for virtual…
MedTech Published Articles L.E.K.’s Take on China Medtech: Optimistic Macro View, Short-Term Hit Hard March 17, 2020 Despite the COVID-19 lockdown, Stephen Sunderland foresees limited disruption
MedTech Presentations COVID-19 Impact on Asia-Pacific Hospitals: Edition 3 June 25, 2020 The top concerns for a number of hospitals (~30%) have shifted towards staff wellness, staff capacity and hospital finances due to revenue loss from…
Life Sciences & Pharma Presentations COVID-19 Funding Snapshot for Pharma Developers/Manufacturers August 21, 2020 The COVID-19 pharmaceutical funding landscape is evolving at a rapid pace, yet several initial insights have emerged
